Abstract:Background Infection remains an important and leading cause of mortality in lupus. We aimed to establish a clinical prediction model for the 3 month all-cause mortality of patients with systemic lupus erythematosus (SLE) and invasive infection in the emergency department. Methods SLE patients classified by 1997 ACR criteria complicating with invasive infection when admitted into the emergency department of our center between May 2015 and June 2018 were included. Invasive infection was defined as deep infection with definite evidence of pathogens or globally judged by the treating physician combining symptoms, lab and imaging tests. Patients clinical and laboratory characteristics at admission were retrospectively collected as baseline data. The outcome was all-cause death within 3 months since baseline. Candidate predictors for multivariable logistic regression were selected by expert opinion based on clinical significance, previous studies and feasibility. A prediction model for all-cause mortality was established by combining independent predictors and evaluated by Receiver Operating Characteristic (ROC) curve analysis. Results A total of 50/130 (38.5%) included patients died cumulatively within 3 month follow-up. Patients were predominantly female (91%) with a mean disease duration of 6.6 years. One hundred and eight (83.1%) patients had lung infection, while 23 (17.7%) patients had blood stream infection. In the final multivariable logistic regression model, lymphocyte count 7.6 mmol/L, maximum prednisone dose in the past60 mg/d, qSOFA score and age at admission were independently predictive for all-cause mortality. However, the history of hydroxychloroquine use was protective. In a combined prediction model, the six predictors were weighted by OR values, making the LUPHAS score ranging from 5 to 22 (table). All patients could be categorized to three group: low-risk (score 5–10), medium-risk (score 11–16) and high-risk (score 17–22). The mortalities were 11.1% (4/36), 32.8% (22/67) and 100% (22/22) in low-risk, medium-risk and high-risk patients, respectively. ROC curve analysis indicated that LUPHAS score could effectively predict all-cause mortality in this population (AUC=0.8595%CI=0.78–0.92). Furthermore, LUPHAS score performed better than the sole qSOFA score (AUC=0.6995%CI=0.59–0.78) in our cohort. The discriminatory performance of LUPHAS score was also superior than CURB-65 score (AUC=0.6995% CI=0.59–0.80) in the subgroup of patients with lung infection (n=108). Conclusions In this large emergency cohort of lupus patients complicating with invasive infection, an impressive high mortality was recorded, underlining that special attention should be paid to these patients. Several independent predictors for all-cause mortality were successfully identified in our study. The real-world evidence-based LUPHAS score might be a promising tool for risk stratification in clinical practice. Funding Source(s): None

Prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus: a retrospective study

Causes of Death in Hospitalized Patients with Systemic Lupus Erythematosus: a 10-Year Multicenter Nationwide Chinese Cohort

Clinical Characteristics and Prognoses of Patients with Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections

Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort

Prognostic analysis of Pneumocystis jirovecii pneumonia in patients with systemic vasculitides: a retrospective cohort study

Prognostic Indicators Of Hospitalized Patients With Systemic Lupus Erythematosus: A Large Retrospective Multicenter Study In China

Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study

Prognostic Analysis of Pneumocystis Jirovecii Pneumonia in Interstitial Lung Disease Patients: A Retrospective Clinical Study

Immune Checkpoint Inhibitor Increased Mortality in Lung Cancer Patients with Pneumocystis Jirovecii Pneumonia: a Comparative Retrospective Cohort Study

Analysis of death causes in 47 patients with systemic lupus erythematosus

THU0036 Discriminating Central Nervous System Infection and Neuropsychiatric Involvement in Patients with Systemic Lupus Erythematosus: A Single-Center Experience

Analysis of locations and pathogens of systemic lupus erythematosus cases died from infection

Prognostic indicators for systemic lupus erythematosus analyzed by Cox proportional hazards model

Analysis of the causes of death of 32 patients with systemic lupus erythematosus

Infection Profile and Risk Factors for Mortality in Patients with End-Stage Renal Disease Attributable to Systemic Lupus Erythematosus: a Two-Center Integrated Study

Clinical features and predictions of in-hospital mortality in 91 patients with systemic lupus erythematosus

Analysis of 5-year survival rate and prognostic indicators of systemic lupus erythematosus

Mortality and prognostic factors in Chinese patients with systemic lupus erythematosus.

134 Mortality risk prediction in lupus patients complicating with invasive infection in the emergency department

412 Mortality in Chinese Patients with Systemic Lupus Erythematosus